Rockwell Medical, Inc.
RMTI
$1.03
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -145.43% | 385.13% | 119.82% | -14.48% | 19.23% |
| Total Depreciation and Amortization | 0.00% | -1.09% | 0.73% | -0.91% | -2.48% |
| Total Amortization of Deferred Charges | 1.14% | 193.33% | -86.30% | -73.65% | 803.26% |
| Total Other Non-Cash Items | -13.68% | 60.79% | -7.92% | 28.76% | -62.69% |
| Change in Net Operating Assets | -99.40% | 544.44% | 91.34% | -328.04% | 87.68% |
| Cash from Operations | -79.77% | 196.46% | 160.59% | -5,434.88% | 98.85% |
| Capital Expenditure | -106.81% | 33.22% | -105.76% | -223.26% | -168.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.06% | -395.61% | -- | -- | -1.68% |
| Cash from Investing | 94.57% | -455.97% | 1,335.25% | -106.92% | 119.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.59% | -147.10% | 63.87% | 79.66% | -114.63% |
| Issuance of Common Stock | 4.35% | 64.78% | 293.39% | -49.00% | -92.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.09% | -- | -- | -- | 188.37% |
| Cash from Financing | 20.71% | 12.01% | 1,060.11% | 123.99% | -105.78% |
| Foreign Exchange rate Adjustments | 0.00% | 66.67% | -- | -- | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 599.79% | -90.90% | 323.02% | -291.26% | 202.00% |